On July 1, 2026, on the occasion of the 105th anniversary of the founding of the Communist Party of China, the Hong Kong SAR Government announced the 2026 Honours List, the 29th such list since Hong Kong's return to China. Among the recipients, Ms. Cheng Cheung Ling, one of the founders of Chia Tai Pharmaceutical, founding president of the Hong Kong Chinese Association, President of Chia Tai Pharmaceutical Group, and Vice Chairwoman of the Board of Directors of Sino Biopharmaceutical Limited, was awarded the "Gold Bauhinia Star".

On June 23, the 17th Annual Meeting of the New Champions 2026 of the World Economic Forum (also known as the "Summer Davos Forum") opened in Dalian, Liaoning.

The 2026 Summer Davos Forum is being held in Dalian, attracting over 1,700 representatives from more than 90 countries and regions, making it the largest "Annual Meeting of the New Champions" in history. On June 24, Premier Li Qiang of the State Council attended the opening ceremony of the 2026 Summer Davos Forum in Dalian and delivered a speech. On the same day, Eric Tse, Chief Executive Officer of Sino Biopharmaceutical Limited (SBP Group, 1177.HK), Chairman of Chia Tai Tianqing, and Chairman of Beijing Tide Pharmaceutical, was invited to attend the "How Far Can China’s Innovation Model Go? " roundtable forum and expressed his views.

On June 25, E-Healthcare Manager released the "Top 100 Chinese Pharmaceutical Innovation Enterprises" list, with Sino Biopharmaceutical Limited (SBP Group, 1177.HK) once again ranking third.